Cardiovascular Deaths During the COVID-19 Pandemic in the United States

被引:140
|
作者
Wadhera, Rishi K. [1 ]
Shen, Changyu
Gondi, Suhas
Chen, Siyan
Kazi, Dhruv S.
Yeh, Robert W.
机构
[1] Harvard Med Sch, 375 Longwood Ave, Boston, MA 02215 USA
关键词
cardiovascular disease; coronavirus disease 2019; COVID-19; pandemic; mortality;
D O I
10.1016/j.jacc.2020.10.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Although the direct toll of COVID-19 in the United States has been substantial, concerns have also arisen about the indirect effects of the pandemic. Hospitalizations for acute cardiovascular conditions have declined, raising concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2). Other factors, including strain on health care systems, may also have had an indirect toll. OBJECTIVES This investigation aimed to evaluate whether population-level deaths due to cardiovascular causes increased during the COVID-19 pandemic. METHODS The authors conducted an observational cohort study using data from the National Center for Health Statistics to evaluate the rate of deaths due to cardiovascular causes after the onset of the pandemic in the United States, from March 18, 2020, to June 2, 2020, relative to the period immediately preceding the pandemic (January 1, 2020 to March 17, 2020). Changes in deaths were compared with the same periods in the previous year. RESULTS There were 397,042 cardiovascular deaths from January 1, 2020, to June 2, 2020. Deaths caused by ischemic heart disease increased nationally after the onset of the pandemic in 2020, compared with changes over the same period in 2019 (ratio of the relative change in deaths per 100,000 in 2020 vs. 2019: 1.11, 95% confidence interval: 1.04 to 1.18). An increase was also observed for deaths caused by hypertensive disease (1.17, 95% confidence interval: 1.09 to 1.26), but not for heart failure, cerebrovascular disease, or other diseases of the circulatory system. New York City experienced a large relative increase in deaths caused by ischemic heart disease (2.39, 95% confidence interval: 1.39 to 4.09) and hypertensive diseases (2.64, 95% confidence interval: 1.52 to 4.56) during the pandemic. More modest increases in deaths caused by these conditions occurred in the remainder of New York State, New Jersey, Michigan, and Illinois but not in Massachusetts or Louisiana. CONCLUSIONS There was an increase in deaths caused by ischemic heart disease and hypertensive diseases in some regions of the United States during the initial phase of the COVID-19 pandemic. These findings suggest that the pandemic may have had an indirect toll on patients with cardiovascular disease. (C) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 50 条
  • [1] Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
    Jacobson, Sheldon H.
    Jokela, Janet A.
    HEALTH CARE MANAGEMENT SCIENCE, 2021, 24 (04) : 661 - 665
  • [2] Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
    Sheldon H. Jacobson
    Janet A. Jokela
    Health Care Management Science, 2021, 24 : 661 - 665
  • [3] Increases in ?deaths of despair? during the COVID-19 pandemic in the United States and the United Kingdom
    Angus, C.
    Buckley, C.
    Tilstra, A. M.
    Dowd, J. B.
    PUBLIC HEALTH, 2023, 218 : 92 - 96
  • [4] Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic
    Friedman, Joseph
    Gjersing, Linn
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2023, 51 (01) : 53 - 57
  • [5] Temporal variation of excess deaths from diabetes during the COVID-19 pandemic in the United States
    Yao, Xiaoxin I.
    Han, Lefei
    Sun, Yangbo
    He, Daihai
    Zhao, Shi
    Ran, Jinjun
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (04) : 483 - 489
  • [6] Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States
    Lv, Fan
    Gao, Xu
    Huang, Amy Huaishiuan
    Zu, Jian
    He, Xinyuan
    Sun, Xiaodan
    Liu, Jinli
    Gao, Ning
    Jiao, Yang
    Keane, Margaret G.
    Zhang, Lei
    Yeo, Yee Hui
    Wang, Youfa
    Ji, Fanpu
    ECLINICALMEDICINE, 2022, 54
  • [7] Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic
    Kleinman, Robert A.
    Sanches, Marcos
    DRUG AND ALCOHOL DEPENDENCE, 2023, 242
  • [8] The Evolution of Excess Deaths in the United States during the First 2 Years of the COVID-19 Pandemic
    Ruhm, Christopher J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2023, 192 (12) : 1949 - 1959
  • [9] Excess Deaths of Gastrointestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic in the United States
    Han, Lefei
    Shi, Haoting
    Li, Yongxuan
    Qi, Hongchao
    Wang, Yuhua
    Gu, Jiawei
    Wu, Jiayin
    Zhao, Shi
    Cao, Peihua
    Xu, Lan
    Deng, Xiaobei
    Yao, Xiaoxin I.
    Ran, Jinjun
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2023, 68
  • [10] Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
    Banerjee, Amitava
    Chen, Suliang
    Pasea, Laura
    Lai, Alvina G.
    Katsoulis, Michail
    Denaxas, Spiros
    Nafilyan, Vahe
    Williams, Bryan
    Wong, Wai Keong
    Bakhai, Ameet
    Khunti, Kamlesh
    Pillay, Deenan
    Noursadeghi, Mahdad
    Wu, Honghan
    Pareek, Nilesh
    Bromage, Daniel
    McDonagh, Theresa A.
    Byrne, Jonathan
    Teo, James T. H.
    Shah, Ajay M.
    Humberstone, Ben
    Tang, Liang, V
    Shah, Anoop S., V
    Rubboli, Andrea
    Guo, Yutao
    Hu, Yu
    Sudlow, Cathie L. M.
    Lip, Gregory Y. H.
    Hemingway, Harry
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (14) : 1599 - 1608